Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine uterosacral ligament injection for postoperative pain after total abdominal hysterectomy
IRCT20230522058253N5Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of bupivacaine in postoperative pain (3 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoint: Pain levels of patients after laparotomy hysterectomy in the study groups. Started Oct 2024; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20230522058253N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230522058253N5.